Antimicrobial resistance poses a grave health concern, particularly in Low- and Middle-Income group nations with the countries bearing the burden of numerous drug-resistant pathogens.

The rising threat of AMR calls for a strong and structured Antimicrobial Stewardship (AMS) to regulate antimicrobial use.

India bears the largest burden of TB in the world, accounting for over 28% cases. While the public sector offers structured care under NTEP, the private sector remains the first point of contact for 50-80% of the patients.

During the COVID-19 pandemic, genomic surveillance was crucial for early outbreak detection, devising intervention and tracking progress.

India bears a huge burden of drug-resistant pathogens, posing a threat to health security The widespread unregulated use of antimicrobials in homes and hospitals is a major contributory factor to the rise and spread of drug-resistant pathogens.

TB patients require 6-months long intensive treatment to cure the disease. However, non-adherence to treatment or irregular adherence are common, leading to increased risk of drug resistance, disease relapse and mortality among the patients.

Over 20% of children died in 2008 from vaccine preventable diseases owing to delays in vaccination.

As India embarked on the largest ever vaccination drive in the wake of COVID-19 pandemic, it became imperative to ensure an impeccable supply chain, meticulous operations planning and cost and budget estimation for the success of the drive.

COVID-19 was an unprecedented health crisis globally, bringing life to a standstill. As health systems crumbled in its wake, its impact was felt far and wide, especially in India, with around 33 million confirmed cases and 445,000 fatalities as on 3 September 2020.